Geron Corporation (GERN) - NASDAQ
Company Description
Geron Corp. discovers and develops therapeutic products for cancer. It is a clinical stage biopharmaceutical company developing a telomerase inhibitor, imetelstat, in hematologic myeloid malignancies. The company's imetelstat, their sole product candidate, is a potent and specific inhibitor of... More
Sector: Healthcare
Industry: Biotechnology
Country: United States